KURLAND FRED 4
4 · Aridis Pharmaceuticals, Inc. · Filed Oct 5, 2021
Insider Transaction Report
Form 4
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Stock Options
2021-10-04+20,000→ 74,575 totalExercise: $3.60Exp: 2031-10-04→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options vest in equal installments over 48 months, beginning on October 4, 2021.